Back to AZN Stock Lookup

AZN Related Hot List

Oct 29, 2009 07:02 AM AstraZeneca plc (AZN) Tops Q3 EPS by 30c
Jul 30, 2009 07:14 AM AstraZeneca (AZN) Tops Q2 EPS by 24c; Guides Higher
Jul 7, 2009 08:21 AM Mylan (MYL) Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex
Mar 11, 2009 08:27 AM Dynavax Technologies (DVAX) Announces Extension of AstraZeneca (AZN), Eligible To Receive $136M
Dec 8, 2008 04:09 PM Targacept (TRGT) and Partner AstraZeneca (AZN) Said AZD3480 Did Not Meet Primary Endpoints
Nov 19, 2008 10:56 AM AstraZeneca (AZN) Sees FY08 Adj-EPS at Low End of $4.90-$5.05 Range
Oct 30, 2008 07:12 AM AstraZeneca (AZN) Tops Q3 Views; Raises Guidance
Sep 15, 2008 04:19 PM AstraZeneca (AZN) and Targacept (TRGT) Announce from Phase 2b Study of AZD3480 Did Not Meet Criteria
Jul 26, 2007 07:18 AM Bristol-Myers Squibb (BMY) Reports Q2 Earnings, Raises FY07 EPS and Guides for FY08
Apr 23, 2007 07:16 AM AstraZeneca PLC (AZN) Acquires MedImmune (MEDI) for $58/Share
Mar 19, 2007 07:40 AM AtheroGenics (AGIX) Reports ARISE Phase III Clinical Study Doesn't Meet Enpoint
Jan 31, 2007 08:26 AM Palatin Technologies (PTN) Higher On Collaboration Deal with AstraZeneca
Dec 27, 2006 08:58 AM Targacept (TRGT) Receives $20 Million Milestone Payment from AstraZeneca (AZN)
Oct 26, 2006 07:11 AM Renovis (RNVS) Said NXY-059 Fails to Meet Trial Endpoints
Sep 21, 2006 08:04 AM POZEN (POZN) Receives $40M Payment from AstraZeneca (AZN); Revised 2006 Guidance
Sep 6, 2006 04:03 PM Dynavax (DVAX) In Collaboration with AstraZeneca for TLR-9, Could Be Worth Up to $136M
Aug 2, 2006 07:22 AM POZEN (POZN) in Global Collaboration with AstraZeneca for Pain Treatment
May 15, 2006 07:22 AM AstraZeneca (AZN) Acquires Cambridge Antibody (CATG)
Apr 27, 2006 09:38 AM AstraZeneca (AZN) Tops Q1 EPS Views; Guided Higher
Feb 28, 2006 07:03 AM PDII Announces Termination of AstraZeneca Fee-for-Service Contract
Feb 14, 2006 09:03 AM AZN withdraws Exanta, due to new safety data - Bloomberg
Feb 10, 2006 09:27 AM PDII Lower on Expected Reductions from AstraZeneca
Dec 22, 2005 09:42 AM AGIX and AZN in License and Commercialization Agreement Worth Up to $1B
Jul 11, 2005 09:21 AM AVN in Deal with AstraZeneca PLC
May 23, 2005 04:31 PM New Study Shows Side Effects from AZN's Crestor is Higher Than Other Statins
May 4, 2005 07:17 AM RNVS Says Saint I Phase III Trial Demonstrated a Statistically Significant Reduction in Disability
Apr 19, 2005 08:11 AM GNTA Genasense Increases Anti-Tumor Activity of Iressa
Apr 1, 2005 08:41 AM AZN Gets FDA Approval for NEXIUM

Back to AZN Stock Lookup